Cargando…

Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function

BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be a...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vitto, Humberto, Ryu, Joohyun, Calderon-Aparicio, Ali, Monts, Josh, Dey, Raja, Chakraborty, Abhijit, Lee, Mee-Hyun, Bode, Ann M., Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731476/
https://www.ncbi.nlm.nih.gov/pubmed/33303020
http://dx.doi.org/10.1186/s40170-020-00234-5
_version_ 1783621906108252160
author De Vitto, Humberto
Ryu, Joohyun
Calderon-Aparicio, Ali
Monts, Josh
Dey, Raja
Chakraborty, Abhijit
Lee, Mee-Hyun
Bode, Ann M.
Dong, Zigang
author_facet De Vitto, Humberto
Ryu, Joohyun
Calderon-Aparicio, Ali
Monts, Josh
Dey, Raja
Chakraborty, Abhijit
Lee, Mee-Hyun
Bode, Ann M.
Dong, Zigang
author_sort De Vitto, Humberto
collection PubMed
description BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be accessed to exploit the underlying mechanism(s) explaining how p53-deficient tumors promote cell survival remains elusive. METHODS: We performed protein-protein interaction studies to demonstrate that ERRα binds to p53. Moreover, we used gene silencing and pharmacological approaches in tandem with quantitative proteomics analysis by SWATH-MS to investigate the role of the ERRα/p53 complex in mitochondrial biogenesis and function in colon cancer. Finally, we designed in vitro and in vivo studies to investigate the possibility of targeting colon cancers that exhibit defects in p53. RESULTS: Here, we are the first to identify a direct protein-protein interaction between the ligand-binding domain (LBD) of ERRα and the C-terminal domain (CTD) of p53. ERRα binds to p53 regardless of p53 mutational status. Furthermore, we show that the ERRα and p53 complex cooperatively control mitochondrial biogenesis and function. Targeting ERRα creates mitochondrial metabolic stresses, such as production of reactive oxygen species (ROS) and mitochondrial membrane permeabilization (MMP), leading to a greater cytotoxic effect that is dependent on the presence of p53. Pharmacological inhibition of ERRα impairs the growth of p53-deficient cells and of p53 mutant patient-derived colon xenografts (PDX). CONCLUSIONS: Therefore, our data suggest that by using the status of the p53 protein as a selection criterion, the ERRα/p53 transcriptional axis can be exploited as a metabolic vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-020-00234-5.
format Online
Article
Text
id pubmed-7731476
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77314762020-12-15 Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function De Vitto, Humberto Ryu, Joohyun Calderon-Aparicio, Ali Monts, Josh Dey, Raja Chakraborty, Abhijit Lee, Mee-Hyun Bode, Ann M. Dong, Zigang Cancer Metab Research BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be accessed to exploit the underlying mechanism(s) explaining how p53-deficient tumors promote cell survival remains elusive. METHODS: We performed protein-protein interaction studies to demonstrate that ERRα binds to p53. Moreover, we used gene silencing and pharmacological approaches in tandem with quantitative proteomics analysis by SWATH-MS to investigate the role of the ERRα/p53 complex in mitochondrial biogenesis and function in colon cancer. Finally, we designed in vitro and in vivo studies to investigate the possibility of targeting colon cancers that exhibit defects in p53. RESULTS: Here, we are the first to identify a direct protein-protein interaction between the ligand-binding domain (LBD) of ERRα and the C-terminal domain (CTD) of p53. ERRα binds to p53 regardless of p53 mutational status. Furthermore, we show that the ERRα and p53 complex cooperatively control mitochondrial biogenesis and function. Targeting ERRα creates mitochondrial metabolic stresses, such as production of reactive oxygen species (ROS) and mitochondrial membrane permeabilization (MMP), leading to a greater cytotoxic effect that is dependent on the presence of p53. Pharmacological inhibition of ERRα impairs the growth of p53-deficient cells and of p53 mutant patient-derived colon xenografts (PDX). CONCLUSIONS: Therefore, our data suggest that by using the status of the p53 protein as a selection criterion, the ERRα/p53 transcriptional axis can be exploited as a metabolic vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-020-00234-5. BioMed Central 2020-12-10 /pmc/articles/PMC7731476/ /pubmed/33303020 http://dx.doi.org/10.1186/s40170-020-00234-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
De Vitto, Humberto
Ryu, Joohyun
Calderon-Aparicio, Ali
Monts, Josh
Dey, Raja
Chakraborty, Abhijit
Lee, Mee-Hyun
Bode, Ann M.
Dong, Zigang
Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title_full Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title_fullStr Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title_full_unstemmed Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title_short Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
title_sort estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731476/
https://www.ncbi.nlm.nih.gov/pubmed/33303020
http://dx.doi.org/10.1186/s40170-020-00234-5
work_keys_str_mv AT devittohumberto estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT ryujoohyun estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT calderonaparicioali estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT montsjosh estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT deyraja estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT chakrabortyabhijit estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT leemeehyun estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT bodeannm estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction
AT dongzigang estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction